10/29
07:28 am
xrtx
XORTX Announces Closing of US$1.1 Million Registered Direct Offering [Canadian Business Journal (Canada)]
Low
Report
XORTX Announces Closing of US$1.1 Million Registered Direct Offering [Canadian Business Journal (Canada)]
10/29
07:00 am
xrtx
XORTX Announces Closing of US$1.1 Million Registered Direct Offering
Low
Report
XORTX Announces Closing of US$1.1 Million Registered Direct Offering
10/21
09:28 am
xrtx
XORTX Announces Pricing of US$1.1 Million Registered Direct Offering [Canadian Business Journal (Canada)]
Low
Report
XORTX Announces Pricing of US$1.1 Million Registered Direct Offering [Canadian Business Journal (Canada)]
10/21
08:00 am
xrtx
XORTX Announces Pricing of US$1.1 Million Registered Direct Offering
Medium
Report
XORTX Announces Pricing of US$1.1 Million Registered Direct Offering
10/20
08:34 pm
xrtx
XORTX Issues Correction Notice and XORTX Announces 180-Day Extension to Regain Compliance with Nasdaq Minimum Bid Price Deficiency
Low
Report
XORTX Issues Correction Notice and XORTX Announces 180-Day Extension to Regain Compliance with Nasdaq Minimum Bid Price Deficiency
10/20
06:45 pm
xrtx
XORTX Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency
Low
Report
XORTX Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency
10/17
07:28 am
xrtx
XORTX Announces Acquisition of Renal Anti-Fibrotic Therapeutic Program from Vectus Biosystems [Canadian Business Journal (Canada)]
High
Report
XORTX Announces Acquisition of Renal Anti-Fibrotic Therapeutic Program from Vectus Biosystems [Canadian Business Journal (Canada)]
10/17
07:00 am
xrtx
XORTX Announces Acquisition of Renal Anti-Fibrotic Therapeutic Program from Vectus Biosystems
Neutral
Report
XORTX Announces Acquisition of Renal Anti-Fibrotic Therapeutic Program from Vectus Biosystems